Literature DB >> 27007946

Myeloid Sarcoma of the Hepatobiliary System: A Case Series and Review of the Literature.

Kelly J Norsworthy1, Bhavana Bhatnagar, Zeba N Singh, Ivana Gojo.   

Abstract

Myeloid sarcoma (MS) is a rare extramedullary presentation of myeloid malignancies, most commonly seen in association with acute myeloid leukemia (AML). Although MS can develop in any organ, the involvement of the hepatobiliary system is rare. With clinical manifestations of jaundice, abdominal pain and other gastrointestinal symptoms, MS presenting at this location can be a challenge to diagnose, particularly in patients with no known history of hematologic malignancy. This may cause delay in proper management. Here we report 3 cases from a single institution and a review of the literature concerning the epidemiology, clinical presentation, treatment and outcomes in patients with MS of the liver, biliary tree and pancreas.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27007946     DOI: 10.1159/000444516

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  A Case of Untreated Myeloid Sarcoma of the Pancreas Head Region: Diagnostic Process of AML Subtyping in an Autoptic Case.

Authors:  Yuki Fukumura; Gentaro Taniguchi; Ai Koyanagi; Yuki Horiuchi; Tomonori Ochiai; Yoko Tabe; Katsuhiro Sano; Yifare Maimaitiaili; Naomi Otsuji; Karin Ashizawa; Takashi Yao
Journal:  Case Rep Pathol       Date:  2021-12-21

2.  Liver cancer concurrent with chronic myelocytic leukemia and extreme thrombocytosis: a rare case report.

Authors:  Ping Han; Zhi-Qiang Han; Xia Mao; Jin Wang; Qin-Lu Li; Min Xiao; Li Meng; De-An Tian; Zhen-Ya Hong
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

Review 3.  Diagnosis and surgical treatment of primary isolated aggressive lumbar myeloid sarcoma: a rare case report and review of the literatures.

Authors:  Cheng-Rui Bai; Xiang Li; Jing-Shi Wang; Jin-Jun Li; Ning Liu; Qi Fei; Dong Li; Yong Yang
Journal:  BMC Musculoskelet Disord       Date:  2021-02-24       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.